课题基金 / 基金详情

The identification of prostate cancer susceptible gene by whole genome search and candidate gene approach

The identification of prostate cancer susceptible gene by whole genome search and candidate gene approach
全基因组搜索和候选基因方法鉴定前列腺癌易感基因
批准号:
16591600
负责人:
YOKOMIZO Akira
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

YOKOMIZO Akira的其他基金

相似基金

相关文献

中文摘要
翻译
前言与目的:遗传多态性可能影响前列腺癌(Pca)的易感性。通过连锁分析,从美国的家族病例中鉴定出HPC2/ELAC2基因。HER-2基因是原癌基因,编码跨膜酪氨酸激酶受体,在包括前列腺癌在内的许多人类癌症中起重要作用。为了确定HPC/ELAC2和HER2基因与日本Pca的关系,我们分析了这两个基因在散发性Pca患者和匹配对照中多态性位点的频率。方法:对日本散发性Pca患者(n=285)和匹配对照(n=233)进行HPC/ELAC2基因的Ser257Leu和Ala541Thr基因分型,HER-2基因的Ile655Val基因分型。对照组为无癌史的日本男性,包括前列腺癌和正常PSA水平(低于4.0ng/m1)。统计学分析采用Fisher精确检验和logistic回归分析。结果:我们观察到Pca患者HPC/ELAC2基因Thr541的频率(8.4%)显著高于对照组(2.1%)(p=0.0030,优势比(OR) = 4.02)。HER-2基因中Va1655在Pca中的表达频率也显著降低(癌组14.7%,对照组26.2%,p=0.0025, OR=0.476)。结论:我们的研究结果表明,HPC/ELAC2中Thr541在日本散发性Pca易感性中具有显著意义(OR =4.02)。Thr 541多态性在美国首次被报道与家族性Pca有关。在我们的分析中,在日本的散发病例中也观察到类似的现象。而在日本的Pca患者中,HER2中Va1655的频率明显较低。此前有报道称,该Va1655Val在乳腺癌患者中出现的频率明显更高。前列腺癌和乳腺癌之间的相反观察结果可能受到这两种癌症的激素环境的影响。
英文摘要
Introduction and Objective : The genetic polymorphisms may affect the of prostate cancer (Pca) susceptibility. HPC2/ELAC2 gene was identified by linkage analysis from familial cases in USA. While, HER-2 gene is a proto-oncogene, encoding a transmembrane tyrosine kinase receptor that has an important role in many human cancers including Pca. To determine the association of HPC/ELAC2 and HER2 gene with Japanese Pca, we analyzed the frequency of polymorphic sites of these two genes in sporadic Pca patients and matched controls.Methods : We genotyped at Ser257Leu and Ala541Thr in HPC/ELAC2 gene, and at Ile655Val in HER-2 gene in sporadic Japanese Pca patients (n=285) and matched controls (n=233). Controls were unrelated Japanese men who had no history of cancer including Pca and normal PSA level (less than 4.0ng/m1). Statistical analyses were performed by Fisher's exact test and logistic regression analysis.Results : We observed a significantly higher frequency of the Thr541 in HPC/ELAC2 gene in Pca patients (8.4%) compared to the control group (2.1%) (p=0.0030, Odds Ratio (OR) = 4.02). Also Va1655 in HER-2 gene was significantly lower frequency in Pca (14.7 % in cancer vs. 26.2 % in control, p=0.0025, OR=0.476).Conclusions : Our results indicate that Thr541 in HPC/ELAC2 has a significance (OR =4.02) in the predisposition of sporadic Pca in Japan. The Thr 541 polymorphism was first reported to link to familial Pca in USA. In our analyses, similar phenomenon was observed in sporadic cases in Japan. While, the frequency of Va1655 in HER2 was significantly lower in Pca patients in Japan. This Va1655Val was previously reported that significant higher frequency was observed in breast cancer patients. This opposite observation between Pca and breast cancer may be affected by hormonal environment of these two cancers.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cancergencyto.2004.03.015
发表时间: 2004-11-01
期刊: CANCER GENETICS AND CYTOGENETICS
影响因子: --
作者: [Debes, JD, Yokomizo, A, Thibodeau, SN]
通讯作者: Thibodeau, SN
DOI: 10.1002/pros.20119
发表时间: 2005
期刊: The Prostate
影响因子: --
作者: [A. Yokomizo;H. Koga;N. Kinukawa;T. Tsukamoto;Y. Hirao;H. Akaza;M. Mori;S. Naito]
通讯作者: A. Yokomizo;H. Koga;N. Kinukawa;T. Tsukamoto;Y. Hirao;H. Akaza;M. Mori;S. Naito
DOI: 10.1002/pros.20107
发表时间: 2004-11
期刊: The Prostate
影响因子: --
作者: [A. Yokomizo;H. Koga;N. Kinukawa;T. Tsukamoto;Y. Hirao;H. Akaza;M. Mori;S. Naito]
通讯作者: A. Yokomizo;H. Koga;N. Kinukawa;T. Tsukamoto;Y. Hirao;H. Akaza;M. Mori;S. Naito
The association analysis of Glutathion S-Transferase P1 Polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy.
谷胱甘肽S-转移酶P1多态性与M-VAC化疗后尿路上皮癌易感性及骨髓抑制的关联分析
DOI: --
发表时间: 2007
期刊: Int. J. Urol (In press)
影响因子: --
作者: [Iwasaki M, Hayashi Y, Kamibayashi T, Mashikmo T., Hayashi Y., 林 行雄, Yokomizo A. et al.]
通讯作者: Yokomizo A. et al.
共 12 条
    The identification of molecular mechanisms of androgen receptor regulation and novel therapeutic target in prostate cancer
    • 批准号:
      22591769
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      YOKOMIZO Akira
    • 依托单位:
    国内基金
    海外基金
    聚谷氨酰胺(PolyQ)疾病致病蛋白构象多态性的研究及应用
    • 批准号:
      31970748
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2019
    • 负责人:
      付玉华
    • 依托单位:
    急性一氧化碳中毒后迟发性脑病易感基因的筛选
    • 批准号:
      81141071
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2011
    • 负责人:
      顾仁骏
    • 依托单位:
    全基因组micro-RNA种子区结合序列SNP标志体系与乳腺癌发病风险的关联及相关功能研究
    • 批准号:
      81172762
    • 项目类别:
      面上项目
    • 资助金额:
      68.0万元
    • 批准年份:
      2011
    • 负责人:
      陈可欣
    • 依托单位:
    遗传多态性对第三代β受体阻滞剂降压疗效的影响及机理研究
    • 批准号:
      81102508
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      19.0万元
    • 批准年份:
      2011
    • 负责人:
      司大勇
    • 依托单位: